宁波市第一医院是中国浙江省宁波市一所公立医院。医院前身为1913年建成的鄞县公立医院，为浙江最早建立的公立医院之一。1954年10月，医院改为现名，目前医院为三级甲等综合性医院，为宁波大学医学院的教学医院。

During the past decade, Ningbo first hospital conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 7 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 6 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ningbo first hospital" #1 sponsor was "Ningbo No. 1 Hospital" with 23 trials, followed by "Eli Lilly and Company" with 10 trials sponsored, "First Affiliated Hospital of Zhejiang University" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ningbo first hospital" #1 collaborator was "Peking University" with 4 trials as a collaborator, "Ningbo No. 1 Hospital" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "First Affiliated Hospital of Kunming Medical University" with 2 trials as a collaborator and "First Affiliated Hospital of Wenzhou Medical University" with 2 trials as a collaborator. Other collaborators include 159 different institutions and companies that were collaborators in the rest 162 trials.

According to Clinical.Site data, the most researched conditions in "Ningbo first hospital" are "Bowel Preparation" (4 trials), "Obesity" (4 trials), "Nonalcoholic Fatty Liver Disease" (3 trials), "Prostatic Neoplasms" (3 trials) and "Colonoscopy" (2 trials). Many other conditions were trialed in "Ningbo first hospital" in a lesser frequency.

Most popular intervention types in "Ningbo first hospital" are "Drug" (39 trials), "Device" (10 trials), "Other" (10 trials), "Behavioral" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Baricitinib" (3 trials), "lifestyle intervention" (3 trials), "no intervention" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ningbo first hospital" are 65 trials for "All" genders, 9 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ningbo first hospital". 5 are not yet recruiting, 34 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Ningbo first hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ningbo first hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 19 trials that are defined as “Not Applicable".